|
|
Blood, 1 May 2004, Vol. 103, No. 9, pp. 3388-3395.
Prepublished online as a Blood First Edition Paper on January 15, 2004; DOI 10.1182/blood-2003-09-3275.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1)
Kaisa Koskinen,
Petri J. Vainio,
David J. Smith,
Marjo Pihlavisto,
Seppo Ylä-Herttuala,
Sirpa Jalkanen, and
Marko Salmi
From the MediCity Research Laboratory and Department of Medical Microbiology, Turku University, Turku, Finland; the National Public Health Institute, Turku, Finland; Biotie Therapies, Turku, Finland; and the A. I. Virtanen Institute and Department of Medicine, University of Kuopio, Kuopio, Finland.
Polymorphonuclear leukocytes (PMNs) migrate from the blood into areas of inflammation by binding to the endothelial cells of blood vessels via adhesion molecules. Vascular adhesion protein-1 (VAP-1) is one of the molecules mediating leukocyte-endothelial cell interactions. It is also an endothelial cell-surface enzyme (amine oxidase) that produces reactive oxygen species during the catalytic reaction. To study the role of the enzymatic activity of VAP-1 in PMN extravasation, we used an enzymatically inactive VAP-1 mutant, specific amine oxidase inhibitors (including a novel small molecule compound), and anti-VAP-1 antibodies in several flow-dependent models. The enzyme inhibitors diminished PMN rolling on and transmigration through human endothelial cells under conditions of laminar shear stress in vitro. Notably, the enzyme inactivating point mutation abolished the capacity of VAP-1 to mediate transmigration. Moreover, the new VAP-1 inhibitor effectively prevented the extravasation of PMNs in an animal model of inflammation. These data show that the oxidase activity of VAP-1 controls PMN exit from the blood during the relatively poorly understood transmigration step. (Blood. 2004;103:3388-3395)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
VAP-1: a new anti-inflammatory target?
- Melanie J. Welham
Blood 2004 103: 3250-3251.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K. Noda, H. She, T. Nakazawa, T. Hisatomi, S. Nakao, L. Almulki, S. Zandi, S. Miyahara, Y. Ito, K. L. Thomas, et al.
Vascular adhesion protein-1 blockade suppresses choroidal neovascularization
FASEB J,
August 1, 2008;
22(8):
2928 - 2935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Noda, S. Miyahara, T. Nakazawa, L. Almulki, S. Nakao, T. Hisatomi, H. She, K. L. Thomas, R. C. Garland, J. W. Miller, et al.
Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis
FASEB J,
April 1, 2008;
22(4):
1094 - 1103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. O'Rourke, E. Y. Wang, A. Miller, E. M. Podar, K. Scheyhing, L. Huang, C. Kessler, H. Gao, H.-T. Ton-Nu, M. T. MacDonald, et al.
Anti-Inflammatory Effects of LJP 1586 [Z-3-Fluoro-2-(4-methoxybenzyl)allylamine Hydrochloride], an Amine-Based Inhibitor of Semicarbazide-Sensitive Amine Oxidase Activity
J. Pharmacol. Exp. Ther.,
February 1, 2008;
324(2):
867 - 875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Jalkanen and M. Salmi
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2008;
28(1):
18 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Koskinen, S. Nevalainen, M. Karikoski, A. Hanninen, S. Jalkanen, and M. Salmi
VAP-1-Deficient Mice Display Defects in Mucosal Immunity and Antimicrobial Responses: Implications for Antiadhesive Applications
J. Immunol.,
November 1, 2007;
179(9):
6160 - 6168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Jalkanen, M. Karikoski, N. Mercier, K. Koskinen, T. Henttinen, K. Elima, K. Salmivirta, and M. Salmi
The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding
Blood,
September 15, 2007;
110(6):
1864 - 1870.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Holmen, E. Elsheikh, M. Christensson, J. Liu, A.-S. Johansson, A. R. Qureshi, S. Jalkanen, and S. Sumitran-Holgersson
Anti Endothelial Cell Autoantibodies Selectively Activate SAPK/JNK Signalling in Wegener's Granulomatosis
J. Am. Soc. Nephrol.,
September 1, 2007;
18(9):
2497 - 2508.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Salmi and S. Jalkanen
Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans
Blood,
September 1, 2006;
108(5):
1555 - 1561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Yu, L.-X. Lu, H. Fan, M. Kazachkov, Z.-J. Jiang, S. Jalkanen, and C. Stolen
Involvement of Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination in Lipopolysaccharide-Induced Pulmonary Inflammation
Am. J. Pathol.,
March 1, 2006;
168(3):
718 - 726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Holmen, E. Elsheikh, P. Stenvinkel, A. R. Qureshi, E. Pettersson, S. Jalkanen, and S. Sumitran-Holgersson
Circulating Inflammatory Endothelial Cells Contribute to Endothelial Progenitor Cell Dysfunction in Patients with Vasculitis and Kidney Involvement
J. Am. Soc. Nephrol.,
October 1, 2005;
16(10):
3110 - 3120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. T. Airenne, Y. Nymalm, H. Kidron, D. J. Smith, M. Pihlavisto, M. Salmi, S. Jalkanen, M. S. Johnson, and T. A. Salminen
Crystal structure of the human vascular adhesion protein-1: Unique structural features with functional implications
Protein Sci.,
August 1, 2005;
14(8):
1964 - 1974.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Aurrand-Lions, C. Lamagna, J. P. Dangerfield, S. Wang, P. Herrera, S. Nourshargh, and B. A. Imhof
Junctional Adhesion Molecule-C Regulates the Early Influx of Leukocytes into Tissues during Inflammation
J. Immunol.,
May 15, 2005;
174(10):
6406 - 6415.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
